Data as of Dec 26
| -0.85 / -0.65%|
The 19 analysts offering 12-month price forecasts for Edwards Lifesciences Corp have a median target of 144.00, with a high estimate of 159.00 and a low estimate of 97.00. The median estimate represents a +10.85% increase from the last price of 129.90.
The current consensus among 24 polled investment analysts is to Buy stock in Edwards Lifesciences Corp. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.